WASHINGTON, D.C.—Resolute Integrity drug-eluting stents showed very strong results in delivery success and inhospital patient outcomes, based on the results of the large-scale, real-world DELIVER study, presented Feb. 24 at the 2013 Cardiovascular Research Technologies (CRT) annual meeting.

WASHINGTON, D.C.—While there may be enough evidence to prove the benefit of performing PCI for chronic total occlusions (CTOs), a randomized controlled trial may still be necessary to convince the naysayers, according to a Feb. 24 presentation at the Cardiovascular Research Technologies (CRT) annual meeting.

Heart disease awareness among women has doubled over the past 15 years, but only approximately one-third of black and Hispanic women are aware of the dangers of heart disease.

Medtronic has reported a small jump in revenue and net earnings in its financial results for its third quarter of fiscal year 2013, which ended Jan. 25.

Implantable cardioverter-defibrillators (ICDs) help to prevent sudden cardiac death, but they cannot cure underlying heart problems and are associated with a diminished quality of life. Yet, physicians tend to downplay these aspects when discussing ICD recommendations with patients.

Dabigatran proved to be an effective extended treatment for venous thromboembolism, with a lower risk of bleeding than warfarin but a higher risk than placebo in two randomized, double-blind studies. Still, it flirted with the upper limit of the predefined noninferiority margin in one study.

The European Commission (EC) has awarded a grant of almost $16 million to the Heart Omics in Ageing consortium project, which aims to prevent heart failure through identifying more specific biomarkers for heart failure and then developing methods for earlier diagnosis and –omic profile targeted treatment of elderly patients at risk of heart failure.    

Early evaluation of coronary artery disease (CAD) in asymptomatic patients with severe aortic stenosis (AS) and risk factors for CAD should be incorporated into practice and guidelines to ensure that timely aortic valve replacement (AVR) and CABG is performed before ischemic myocardial damage occurs, recommended authors of a study in the Feb. 26 issue of the Journal of the American College of Cardiology.